Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

Edward Chung; Vice President - Investor Relations; Bio Rad Laboratories Inc. Unidentified Company Representative. Roop Lakkaraju; Chief Financial Officer, Executive ...

Bio-Rad Laboratories Inc (NYSE:BIO). reported its fourth-quarter 2024 earnings, revealing a slight miss on revenue expectations, with net sales of $668 million compared to a forecast of $681.29 ...